Rare diseases
Investigational molecules
Locations
Back to France3 344 clinical trials in Saint-Cloud, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on Oxaliplatin and Irinotecan for Patients with Metastatic Colorectal Cancer in the Liver
FranceStudy of Regorafenib and Avelumab for Adults with Advanced or Metastatic Solid Tumors
FranceStudy on DF1001, Nivolumab, and Paclitaxel for Patients with Advanced Solid Tumors
FranceStudy on Nivolumab with Drug Combination for Patients with Intermediate Stage Liver Cancer
FranceStudy on [18F]-Fludarabine and Gadoteric Acid for Imaging in Patients with Newly Diagnosed Primary CNS Lymphoma
FranceStudy on Mavorixafor for Treating WHIM Syndrome in Patients
FranceStudy of Ribociclib and Letrozole for Patients with High-Risk Estrogen Receptor-Positive, HER2-Negative Breast Cancer
FranceStudy on the Effects of Verapamil Hydrochloride for Adults with Type 1 Diabetes to Preserve Beta-Cell Function
FranceStudy of Ivosidenib or Enasidenib with Chemotherapy for Patients with Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with IDH1 or IDH2 Mutation
FranceStudy on Niraparib and Dostarlimab for Patients with Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Not Suitable for Platinum Treatment
FranceStudy on the Effect of Aflibercept Injections in Patients with Central Retinal Vein Occlusion (CRVO) and Spontaneous Retinal Arterial Pulsations (SRAPs)
FranceStudy of Ivosidenib and Azacitidine for Patients Aged 18 and Older with Untreated Acute Myeloid Leukemia with IDH1 Mutation
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on lymphoma and multiple myeloma treatments, including studies of novel therapies like duvelisib for T-cell lymphoma and odronextamab for follicular lymphoma.
Several studies are evaluating combination therapies and comparing new treatment approaches against standard care.
Comprehensive research into various types of breast cancer, with particular focus on hormone receptor-positive and triple-negative variants. Studies include early detection methods and novel therapeutic combinations.
Trials incorporate innovative approaches like ctDNA monitoring and targeted therapies.
Research focusing on targeted therapies for various advanced cancers, including studies of biliary tract cancer and non-small cell lung cancer treatments.
Emphasis on immunotherapy combinations and precision medicine approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
